antifungal treatment market share, size, forecast 2022
                     Market Analysis 
The global antifungal treatment market is predicted to touch USD 19,558.0 million at a 4.61% CAGR  
over the forecast period (2017-2023), states the latest Market Research Future (MRFR) report. Fungal 
 infections in the body result from unclean and unhygienic environments where fungal agents thrive.  
Such agents grow by spreading spores, which causes skin infection subsequently or when fungal  
infections are inhaled (systematic). Antifungal drugs or treatment are substances that selectively acts  
against the fungal pathogen in the fungal infection treatment. Allylamines, polyenes, echinocandins,  
pyrimidines, and azoles are the most widely used antifungal treatments.
Various factors are propelling the Anti-Fungal Agents Market growth. Some of these factors,  
according to the Market Research Future report, include rising number of patients with fungal  
diseases, rising geriatric population, growing awareness regarding different fungal infections, rising  
corporate and government initiatives, and rise in population which come in contact with infections  
and resistant fungal strains. Additional factors pushing market growth include the weakened immune  
system, rising disposable income, increased investments in research and development activities,  
private-public partnership agreements in the pharmaceutical sector to develop new and effective  
antifungal drugs, antifungal paint and growing demand for over the counter (OTC) drugs to treat skin  
infections.
Market Segmentation
The MRFR report offers a wide segmental analysis of the antifungal treatment market on the basis of 
 drug class, therapeutic indication, pathogen, and end users.
Based on drug class, the antifungal treatment market is segmented into allylamines, polyenes,  
echinocandins, pyrimidines, azoles, and others. Of these, the azoles segment will have the largest  
share in the market over the forecast period. Azoles are used for treating ocular fungal infections,  
systemic candidiasis, blastomycosis, and candidemia.
Based on therapeutic indication, the antifungal treatment market is segmented into cryptococcosis,  
coccidioidomycosis, candidiasis, and systemic. Of these, the systemic segment will dominate the  
market over the forecast period.
Based on pathogens, the antifungal treatment market is segmented into trichophyton, zygomycetes,  
coccidioides immitis, cryptococcus, aspergillus, candida, and others.
Based on end user, the antifungal treatment market is segmented into dermatology clinics, hospitals  
and clinics, and others.
Key Players
Leading players profiled in the antifungal treatment market report include Bayer AG (Germany),  
Astellas (Japan), Merck & Co., Inc. (U.S), Sanofi (France), Pfizer Inc. (U.S), and Novartis AG  
(Switzerland), among others. Key players have incorporated strategies such as technology launch,  
expansion, partnership, collaboration, and acquisition for gaining a competitive advantage in the  
market.
Regional Analysis
By region, the antifungal treatment market report covers the latest trends and growth opportunities  
across the Americas, the Asia Pacific, Europe, and the Middle East and Africa. Of these, the Americas, 
 particularly North America, will lead the market over the forecast period. This is owing to the rising  
incidences of patients in this region with fungal infections, developed healthcare infrastructure, and  
quick adoption of new antifungal treatments.
The antifungal treatment market in Europe will have the second-largest share in the market over the  
forecast period. Most companies in Europe are emphasizing on R&D of antifungal drugs that in turn,  
is pushing market growth. These companies are getting government funding that is favoring the  
market growth in this region.
The antifungal treatment market in the APAC region is predicted to grow at the fastest pace over the  
forecast period. This is owing to the increasing awareness regarding available fungal infection  
treatments, rising healthcare expenditure, rising adoption of new medical practices, and developing  
healthcare infrastructure.
The antifungal treatment market in the Middle East and Africa is predicted to have a slow growth 
over  the forecast period. This is owing to limited access to healthcare facilities and lack of awareness  
regarding antifungal treatments.
March 2019: Pharmbio Korea has signed a deal with BioSynectics for creating an antifungal 
treatment,  PBK-1819-2. The company will use the nanotechnology of BioSynectics to create the drug. 
The nano-  conversion technology will offer an array of perks such as lower side effects, dietary as 
well as post-  diastolic deviation, and improved bioavailability.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries  
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research  
Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),  
99 Hudson Street,5Th Floor, New York,
New York 10013